Ireland
--:--IST
Latest
Clinical Trials in France / NCT07406516
Recruiting Not applicable

Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk

NCT07406516 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-09-15
Last updated
2026-09-21

Condition(s) studied

Patellar TendinitisJumper's KneeMusculoskeletal InjuriesKnee Injuries

Investigational drug(s) / intervention(s)

The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology at 6 months and 12 months

The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.: Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods (M3, M6, M9, M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy.

The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology at 6 months and 12 months: Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods ( M6 et M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy.

Study summary

This research aims to identify and monitor specific kinematic markers associated with patellar tendinopathy in athletes at risk. Using a markerless motion capture system, vertical jump tests will be analyzed to detect early biomechanical changes in the knees, hips, trunk, and ankles. By comparing injured participants, the study seeks to improve early diagnosis and personalized prevention strategies for patellar tendinopathy.

Eligibility

Sex
MALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
* Subject aged between 18 and 45 years * Male subject * Regularly participating in physical activity involving jumping (a predisposing factor for patellar tendinopathy) twice a week for at least one year. * Participants affiliated with or covered by a social security scheme SPECIFIC INCLUSION CRITERIA FOR THE PATELLAR TENDINOPATHY GROUP Patients with at least 2 of the following 3 criteria: * Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002) * VISA-PF \< 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018) * Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020) SPECIFIC INCLUSION CRITERIA FOR THE HEALTHY GROUP Patients with 0 or 1 of the following 3 criteria: * Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002) * VISA-PF \< 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018) * Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020) Non inclusion Criteria: * Significant medical and surgical history involving the lower limbs (e.g., ACL ligament reconstruction, meniscectomy, etc.) * Contraindications to participating in sports activities * Other pathologies involving the lower limbs (\< 6 months), e.g., torn knee ligaments, ankle sprain, knee sprain, etc. * Participants who have not given their informed consent * Participants subject to legal protection measures (legal guardianship, conservatorship, curatorship) * Participants deprived of their liberty by judicial or administrative decision

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sports Medicine and Traumatology LAPEYRONIE Hospital - Montpellier University Hospital Montpellier France Recruiting

More University Hospital, Montpellier trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07406516 on ClinicalTrials.gov ↗ ← All trials in France